EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry

Lydia G van der Geest iD, Marianne van der Mark, Joanne Verheij, Arantza Farina Sarasqueta, Judith de Vos-Geelen iD, Marc G Besselink, Vincent E de Meijer, Ignace H J T de Hingh, Bert A Bonsing, Philip R de Reuver, Francois E J A Willemssen, Pauline A J Vissers iD und 2 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Lydia G van der Geest und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Registries, Pancreatic Neoplasms, Biliary Tract Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the poor survival and relatively poor performance of hepato‐pancreato‐biliary (HPB) cancers on data quality indicators for cancer registries, we assessed trends in incidence, survival, and data quality of HPB cancers within the Netherlands Cancer Registry (NCR). All primary solid liver, gallbladder, biliary tract, and pancreatic cancers (topography C22‐23‐24‐25) diagnosed between 1989 and 2022 were included ( n = 109,552). Cancer mortality data were obtained from Statistics Netherlands. For incidence and mortality, revised European Age‐Standardised Rates, and for survival, age‐standardised 5‐year relative survival (AS‐5yRS) were calculated. Over time, incidence rates increased for liver (males: 3.0 to 8.2/100,000; females 1.2 to 3.9/100,000), pancreatic (males: 15.8 to 18.5/100,000; females: 11.1 to 15.3/100,000), and biliary tract cancers in males (3.9 to 4.9/100,000; not females: 3.3 to 2.9/100,000). Gallbladder cancer incidence decreased until 2005 (males: 1.5 to 0.8/100,000, females 4.0 to 1.5/100,000). Mortality trends mirrored incidence patterns, with smaller increases. AS‐5yRS improved across all HPB cancers with the largest increase in liver (males: 3.4% to 20.8%; females: 6.7% to 18.3%) and pancreatic cancers (males: 2.3% to 10.4%; females: 3.5% to 11.3%). Since 2010, survival gains for gallbladder (males: 8.4% to 16.3%; females: 12.2% to 15.8%) and biliary tract cancers (males: 11.7% to 19.1%; females: 10.7% to 15.6%) have stagnated. Mortality‐to‐Incidence ratios versus 5‐year relative survival for liver and pancreatic cancers improved toward equilibrium. Data quality improved (e.g., autopsy, unspecified morphology) or remained stable (multiple primaries). Both incidence and survival rates of primary HPB cancers have increased over time. Increased completeness of incidence data was attributed to changed notification sources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesPancreatic NeoplasmsBiliary Tract NeoplasmsLiver NeoplasmsHumansFemaleNetherlandsMaleIncidenceAgedMiddle AgedAged, 80 and overAdultGallbladder NeoplasmsSurvival Rate

Stichwörter der Autor:innen

biliary tractcancerdata qualityepidemiologyincidencelivermortalitypancreassurvival

Autor:innen und Institutionen

  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Department of Medical Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Pathology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Division of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • GROW-Research Institute for Oncology & Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Lydia G van der Geest, Judith de Vos-Geelen, Pauline A J Vissers

Zitieren

APA

van der Geest, L. G., van der Mark, M., Verheij, J., Farina Sarasqueta, A., de Vos-Geelen, J., Besselink, M. G., de Meijer, V. E., de Hingh, I. H. J. T., Bonsing, B. A., de Reuver, P. R., Willemssen, F. E. J. A., Vissers, P. A. J., Visser, O., & Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group (2026). Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer. https://doi.org/10.1002/ijc.70145

Vancouver

van der Geest LG, van der Mark M, Verheij J, Farina Sarasqueta A, de Vos-Geelen J, Besselink MG, et al. Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer. 2026. doi:10.1002/ijc.70145

BibTeX
@article{vanderGeest2026,
  author = {van der Geest, Lydia G and van der Mark, Marianne and Verheij, Joanne and Farina Sarasqueta, Arantza and de Vos-Geelen, Judith and Besselink, Marc G and de Meijer, Vincent E and de Hingh, Ignace H J T and Bonsing, Bert A and de Reuver, Philip R and Willemssen, Francois E J A and Vissers, Pauline A J and Visser, Otto and Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group, Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group},
  title = {Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70145}
}
Kostenlos starten →